A prospective multicentric clinical study to draw gene map of ovarian tumors to guide accurate diagnosis and treatment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036176

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-11-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

case series:nil

Eligibility

Sex/Gender

Female

Age

10 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with ovarian cancer or fallopian tube cancer diagnosed by admission test and able to cooperate with the standardized diagnosis and treatment protocol.

Exclusion criteria

Exclusion criteria: During the operation, pathological types such as mucinous ovarian cancer and borderline ovarian cancer were excluded by pathology, history of other malignant tumors were excluded.

Design outcomes

Primary

Measure	Time frame
Overall survival;Progression-free survival;Evaluation of therapeutic effect;	—

Countries

China

Contacts

Public ContactXipeng Wang

wangxipeng@xinhuamed.com.cn+86 15000573167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026